163 related articles for article (PubMed ID: 25495981)
21. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
[TBL] [Abstract][Full Text] [Related]
22. Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory-antimicrobial agents and their docking studies with COX-1/COX-2 active sites.
Chandak N; Kumar P; Kaushik P; Varshney P; Sharma C; Kaushik D; Jain S; Aneja KR; Sharma PK
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):476-84. PubMed ID: 23777557
[TBL] [Abstract][Full Text] [Related]
23. Compounds from the insect Blaps japanensis with COX-1 and COX-2 inhibitory activities.
Yan YM; Li LJ; Qin XC; Lu Q; Tu ZC; Cheng YX
Bioorg Med Chem Lett; 2015 Jun; 25(12):2469-72. PubMed ID: 25980909
[TBL] [Abstract][Full Text] [Related]
24. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors.
Abdur Rahim M; Praveen Rao PN; Bhardwaj A; Kaur J; Huang Z; Knaus EE
Bioorg Med Chem Lett; 2011 Oct; 21(20):6074-80. PubMed ID: 21890358
[TBL] [Abstract][Full Text] [Related]
25. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.
Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK
Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153
[TBL] [Abstract][Full Text] [Related]
26. Toward the understanding of the molecular basis for the inhibition of COX-1 and COX-2 by phenolic compounds present in Uruguayan propolis and grape pomace.
Paulino M; Alvareda E; Iribarne F; Miranda P; Espinosa V; Aguilera S; Pardo H
J Biomol Struct Dyn; 2016 Dec; 34(12):2643-2657. PubMed ID: 26610257
[TBL] [Abstract][Full Text] [Related]
27. Nectandra amazonum-derived flavonoids as COX-1 inhibitors: in vitro and docking studies.
Valdés-Barrera ID; Cuca-Suarez LE; Coy-Barrera ED
Nat Prod Commun; 2014 May; 9(5):649-52. PubMed ID: 25026711
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Zebardast T; Daraie B; Hedayati M
Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
[TBL] [Abstract][Full Text] [Related]
29. Discovering COX-inhibiting constituents of Morus root bark: activity-guided versus computer-aided methods.
Rollinger JM; Bodensieck A; Seger C; Ellmerer EP; Bauer R; Langer T; Stuppner H
Planta Med; 2005 May; 71(5):399-405. PubMed ID: 15931575
[TBL] [Abstract][Full Text] [Related]
30. Redox and non-redox mechanism of in vitro cyclooxygenase inhibition by natural quinones.
Landa P; Kutil Z; Temml V; Vuorinen A; Malik J; Dvorakova M; Marsik P; Kokoska L; Pribylova M; Schuster D; Vanek T
Planta Med; 2012 Mar; 78(4):326-33. PubMed ID: 22174077
[TBL] [Abstract][Full Text] [Related]
31. Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors.
Shi L; Li ZL; Yang Y; Zhu ZW; Zhu HL
Bioorg Med Chem Lett; 2011 Jan; 21(1):121-4. PubMed ID: 21144750
[TBL] [Abstract][Full Text] [Related]
32. Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development.
Singh S; Pandey VP; Naaz H; Singh P; Dwivedi UN
Comput Biol Med; 2013 Jul; 43(6):744-50. PubMed ID: 23668350
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2.
Seebacher W; Faist J; Presser A; Weis R; Saf R; Kaserer T; Temml V; Schuster D; Ortmann S; Otto N; Bauer R
Eur J Med Chem; 2015 Aug; 101():552-9. PubMed ID: 26197159
[TBL] [Abstract][Full Text] [Related]
34. Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method.
Michaux C; de Leval X; Julémont F; Dogné JM; Pirotte B; Durant F
Eur J Med Chem; 2006 Dec; 41(12):1446-55. PubMed ID: 17030482
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, COX-1/2 inhibition activities and molecular docking study of isothiazolopyridine derivatives.
Świątek P; Strzelecka M; Urniaz R; Gębczak K; Gębarowski T; Gąsiorowski K; Malinka W
Bioorg Med Chem; 2017 Jan; 25(1):316-326. PubMed ID: 27842798
[TBL] [Abstract][Full Text] [Related]
36. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
38. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
[TBL] [Abstract][Full Text] [Related]
39. Hit identification and biological evaluation of anticancer pyrazolopyrimidines endowed with anti-inflammatory activity.
Alcaro S; Artese A; Botta M; Zizzari AT; Orallo F; Ortuso F; Schenone S; Brullo C; Yáñez M
ChemMedChem; 2010 Aug; 5(8):1242-6. PubMed ID: 20564576
[No Abstract] [Full Text] [Related]
40. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.
Anana R; Rao PN; Chen QH; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
